| scholarly article | Q13442814 |
| P2093 | author name string | Wei Wang | |
| Peng Xie | |||
| Ting Wang | |||
| Zhi Chen | |||
| Shunjie Bai | |||
| Xunzhong Qi | |||
| P2860 | cites work | Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation | Q24322925 |
| Feature Article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology | Q24634012 | ||
| The molecular neurobiology of depression | Q24656261 | ||
| Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases | Q26859141 | ||
| Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 | Q28083357 | ||
| dl-3n-butylphthalide prevents stroke via improvement of cerebral microvessels in RHRSP | Q28212709 | ||
| CREB is a regulatory target for the protein kinase Akt/PKB | Q28289946 | ||
| Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase | Q28366319 | ||
| Metabolomics enables precision medicine: "A White Paper, Community Perspective" | Q28831476 | ||
| Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress | Q29618764 | ||
| Time-dependent metabolomic profiling of Ketamine drug action reveals hippocampal pathway alterations and biomarker candidates | Q30423149 | ||
| Social defeat stress causes depression-like behavior with metabolite changes in the prefrontal cortex of rats | Q33614561 | ||
| Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis | Q33623036 | ||
| Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis | Q34029684 | ||
| CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis | Q34049345 | ||
| Dl-3-n-butylphthalide, a natural antioxidant, protects dopamine neurons in rotenone models for Parkinson's disease | Q34180685 | ||
| DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis | Q34230266 | ||
| Proteomics reveals energy and glutathione metabolic dysregulation in the prefrontal cortex of a rat model of depression | Q34751775 | ||
| The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review | Q35071470 | ||
| A standardized protocol for repeated social defeat stress in mice. | Q35561938 | ||
| 1H NMR-based metabolic profiling reveals the effects of fluoxetine on lipid and amino acid metabolism in astrocytes. | Q35585693 | ||
| Association between suicidal behaviour and impaired glucose metabolism in depressive disorders | Q35704636 | ||
| Combined Metabolomics and Proteomics Analysis of Major Depression in an Animal Model: Perturbed Energy Metabolism in the Chronic Mild Stressed Rat Cerebellum. | Q35861541 | ||
| Hypothalamic Proteomic Analysis Reveals Dysregulation of Glutamate Balance and Energy Metabolism in a Mouse Model of Chronic Mild Stress-Induced Depression | Q36031835 | ||
| Long-Term Administration of Dehydroepiandrosterone Accelerates Glucose Catabolism via Activation of PI3K/Akt-PFK-2 Signaling Pathway in Rats Fed a High-Fat Diet | Q36075631 | ||
| GC-MS-Based Metabonomic Profiling Displayed Differing Effects of Borna Disease Virus Natural Strain Hu-H1 and Laboratory Strain V Infection in Rat Cortical Neurons | Q36088686 | ||
| Identification and validation of urinary metabolite biomarkers for major depressive disorder | Q36508139 | ||
| Ethological Evaluation of the Effects of Social Defeat Stress in Mice: Beyond the Social Interaction Ratio | Q36534851 | ||
| Problems associated with long-term treatment with selective serotonin reuptake inhibitors | Q37219382 | ||
| Social stress, therapeutics and drug abuse: preclinical models of escalated and depressed intake | Q37267936 | ||
| Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics | Q37648213 | ||
| PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis. | Q37974734 | ||
| New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors. | Q37978196 | ||
| The Role of Akt in Chronic Liver Disease and Liver Regeneration. | Q39136962 | ||
| Targeted Metabolomic Pathway Analysis and Validation Revealed Glutamatergic Disorder in the Prefrontal Cortex among the Chronic Social Defeat Stress Mice Model of Depression | Q39418875 | ||
| L-3-n-butylphthalide regulates amyloid precursor protein processing by PKC and MAPK pathways in SK-N-SH cells over-expressing wild type human APP695. | Q39640944 | ||
| Differential susceptibility of mitochondrial complex II to inhibition by oxaloacetate in brain and heart. | Q39692392 | ||
| Brain glucose metabolism in an animal model of depression | Q41145105 | ||
| Insight into the metabolic mechanism of Diterpene Ginkgolides on antidepressant effects for attenuating behavioural deficits compared with venlafaxine. | Q41548141 | ||
| Effects of chiral 3-n-butylphthalide on apoptosis induced by transient focal cerebral ischemia in rats. | Q44540430 | ||
| DL-3-n-butylphthalide protects endothelial cells against oxidative/nitrosative stress, mitochondrial damage and subsequent cell death after oxygen glucose deprivation in vitro. | Q45925880 | ||
| l-3-n-Butylphthalide attenuates β-amyloid-induced toxicity in neuroblastoma SH-SY5Y cells through regulating mitochondrion-mediated apoptosis and MAPK signaling | Q46844850 | ||
| DL-3-n-butylphthalide alleviates vascular cognitive impairment induced by chronic cerebral hypoperfusion by activating the Akt/Nrf2 signaling pathway in the hippocampus of rats | Q47364555 | ||
| Hippocampal metabolic differences implicate distinctions between physical and psychological stress in four rat models of depression | Q47562585 | ||
| Post-stroke depression: Mechanisms and pharmacological treatment | Q47617741 | ||
| Metabolite identification in fecal microbiota transplantation mouse livers and combined proteomics with chronic unpredictive mild stress mouse livers | Q47642189 | ||
| GC-MS-based metabolomic study on the antidepressant-like effects of diterpene ginkgolides in mouse hippocampus | Q48046067 | ||
| Metabolomic analysis reveals metabolic disturbances in the prefrontal cortex of the lipopolysaccharide-induced mouse model of depression | Q48057486 | ||
| Proteomic and metabolomic profiling reveals time-dependent changes in hippocampal metabolism upon paroxetine treatment and biomarker candidates | Q48269085 | ||
| Plasma metabonomics as a novel diagnostic approach for major depressive disorder. | Q48760949 | ||
| Short bouts of mild-intensity physical exercise improve spatial learning and memory in aging rats: involvement of hippocampal plasticity via AKT, CREB and BDNF signaling. | Q48854337 | ||
| Dl-3-n-butylphthalide-induced upregulation of antioxidant defense is involved in the enhancement of cross talk between CREB and Nrf2 in an Alzheimer's disease mouse model. | Q48939877 | ||
| Corrigendum: a standardized protocol for repeated social defeat stress in mice. | Q50943770 | ||
| Glucose Transporters in Diabetic Kidney Disease-Friends or Foes? | Q52568352 | ||
| Synaptic activity-induced glycolysis facilitates membrane lipid provision and neurite outgrowth. | Q52609135 | ||
| L-3-n-butylphthalide Promotes Neurogenesis and Neuroplasticity in Cerebral Ischemic Rats. | Q53405673 | ||
| Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression. | Q55266121 | ||
| iTRAQ-based proteomics suggests LRP6, NPY and NPY2R perturbation in the hippocampus involved in CSDS may induce resilience and susceptibility | Q57465000 | ||
| Biomarkers for major depressive and bipolar disorders using metabolomics: A systematic review | Q58573890 | ||
| Depression | Q58617330 | ||
| Integrated Analysis Reveals Altered Lipid and Glucose Metabolism and Identifies NOTCH2 as a Biomarker for Parkinson's Disease Related Depression | Q58780873 | ||
| Memory Impairment Induced by Borna Disease Virus 1 Infection is Associated with Reduced H3K9 Acetylation | Q59354012 | ||
| Integrated Metabolomics and Proteomics Analysis Revealed Second Messenger System Disturbance in Hippocampus of Chronic Social Defeat Stress Rat | Q64061225 | ||
| DL-3-n-butylphthalide improves ventricular function, and prevents ventricular remodeling and arrhythmias in post-MI rats | Q88229239 | ||
| L-3-n-Butylphthalide Regulates Proliferation, Migration, and Differentiation of Neural Stem Cell In Vitro and Promotes Neurogenesis in APP/PS1 Mouse Model by Regulating BDNF/TrkB/CREB/Akt Pathway | Q88575139 | ||
| Dl-3-n-Butylphthalide improves lipopolysaccharide-induced depressive-like behavior in rats: involvement of Nrf2 and NF-κB pathways | Q89250657 | ||
| mGluR5 Facilitates Long-Term Synaptic Depression in a Stress-Induced Depressive Mouse Model | Q90127123 | ||
| The Open Field Test for Measuring Locomotor Activity and Anxiety-Like Behavior | Q90394114 | ||
| Chronic mild stress leads to aberrant glucose energy metabolism in depressed Macaca fascicularis models | Q92159629 | ||
| Akt in cancer: Mediator and more | Q92586326 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 49 | |
| P577 | publication date | 2020-02-03 | |
| P1433 | published in | Translational Psychiatry | Q15716636 |
| P1476 | title | Dl-3-n-butylphthalide attenuates mouse behavioral deficits to chronic social defeat stress by regulating energy metabolism via AKT/CREB signaling pathway | |
| P478 | volume | 10 |
| Q104795022 | CD36 deficiency affects depressive-like behaviors possibly by modifying gut microbiota and the inflammasome pathway in mice | cites work | P2860 |
Search more.